Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients

Authors: Joshua T. Kantrowitz, Daniel C. Javitt, Robert Freedman, Pejman Sehatpour, Lawrence S. Kegeles, Marlene Carlson, Tarek Sobeih, Melanie M. Wall, Tse‐Hwei Choo, Blair Vail, Jack Grinband, Jeffrey A. Lieberman - Neuropsychopharmacology 2020 cited by 49